4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells)

Kuniaki Saito, C. Y. Chen, M. Masana, J. S. Crowley, S. P. Markey, M. P. Heyes

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following-induction of indoleamine 2,3-dioxygenase and other kynurenine-pathway enzymes. In the present study a survey of various cell lines derived from either brain or systemic tissues showed that, while all cells examined responded to interferon-γ by increased conversion of L[13C6]tryptophan into L-kynurenine (human: B-lymphocytes neuroblastoma, glioblastoma, lung, liver, kidney; rat brain microglia, astrocytes and oligodendrocytes), only macrophage-derived cells (peripheral-blood mononuclear cells; THP-1, U-937) and certain liver cells (SKHep1) synthesized [13C6]quinolinic acid. Tumour necrosis factor-α enhanced the effects of interferon-γ in THP-1 cells. Norharmane, 6-chloro-DL-tryptophan and 4-chloro-3-hydroxyanthranilate attenuated quinolinic acid formation by THP-1 cells with IC50 values of 51μM, 58μM and 0.11μM respectively. Norharmane and 6-chloro-DL-tryptophar attenuated L-kynurenine formation with IC50 values of 43μM and 51μM respectively, whereas 4-chloro-3-hydroxyanthranilate had no effect on L-kynurenine accumulation. The reductions in L-kynurenine and quinolinic acid formation are consistent with the reports that norharmane is an inhibitor of indoleamine 2,3-dioxygenase, 6-chloro-DL-tryptophan is metabolized through the kynurenine pathway, and 4-chloro-3-hydroxyanthranilate is an inhibitor of 3-hydroxyanthranilate 3,4-dioxygenase. These results suggest that many tissues may contribute to the production of L-kynurenine following indoleamine 2,3-dioxygenase induction and immune activation. Quinolinic acid may be directly synthesized from L-tryptophan in both macrophages and certain types of liver cells, although uptake of quinolinic acid precursors from blood may contribute to quinolinic acid synthesis in cells that cannot convert L-kynurenine into quinolinic acid.

Original languageEnglish
Pages (from-to)11-14
Number of pages4
JournalBiochemical Journal
Volume291
Issue number1
DOIs
Publication statusPublished - 01-01-1993

Fingerprint

norharman
Quinolinic Acid
Kynurenine
Interferons
Monocytes
Tryptophan
Indoleamine-Pyrrole 2,3,-Dioxygenase
Liver
Brain
Blood
Macrophages
3-Hydroxyanthranilate 3,4-Dioxygenase
Inhibitory Concentration 50
Chemical activation
Tissue
6-chlorotryptophan
4-chloro-3-hydroxyanthranilic acid
Lymphocytes
Oligodendroglia

All Science Journal Classification (ASJC) codes

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

@article{3c6d1d0e0858499ca85341409b9ba84c,
title = "4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells)",
abstract = "Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following-induction of indoleamine 2,3-dioxygenase and other kynurenine-pathway enzymes. In the present study a survey of various cell lines derived from either brain or systemic tissues showed that, while all cells examined responded to interferon-γ by increased conversion of L[13C6]tryptophan into L-kynurenine (human: B-lymphocytes neuroblastoma, glioblastoma, lung, liver, kidney; rat brain microglia, astrocytes and oligodendrocytes), only macrophage-derived cells (peripheral-blood mononuclear cells; THP-1, U-937) and certain liver cells (SKHep1) synthesized [13C6]quinolinic acid. Tumour necrosis factor-α enhanced the effects of interferon-γ in THP-1 cells. Norharmane, 6-chloro-DL-tryptophan and 4-chloro-3-hydroxyanthranilate attenuated quinolinic acid formation by THP-1 cells with IC50 values of 51μM, 58μM and 0.11μM respectively. Norharmane and 6-chloro-DL-tryptophar attenuated L-kynurenine formation with IC50 values of 43μM and 51μM respectively, whereas 4-chloro-3-hydroxyanthranilate had no effect on L-kynurenine accumulation. The reductions in L-kynurenine and quinolinic acid formation are consistent with the reports that norharmane is an inhibitor of indoleamine 2,3-dioxygenase, 6-chloro-DL-tryptophan is metabolized through the kynurenine pathway, and 4-chloro-3-hydroxyanthranilate is an inhibitor of 3-hydroxyanthranilate 3,4-dioxygenase. These results suggest that many tissues may contribute to the production of L-kynurenine following indoleamine 2,3-dioxygenase induction and immune activation. Quinolinic acid may be directly synthesized from L-tryptophan in both macrophages and certain types of liver cells, although uptake of quinolinic acid precursors from blood may contribute to quinolinic acid synthesis in cells that cannot convert L-kynurenine into quinolinic acid.",
author = "Kuniaki Saito and Chen, {C. Y.} and M. Masana and Crowley, {J. S.} and Markey, {S. P.} and Heyes, {M. P.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1042/bj2910011",
language = "English",
volume = "291",
pages = "11--14",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "1",

}

4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells). / Saito, Kuniaki; Chen, C. Y.; Masana, M.; Crowley, J. S.; Markey, S. P.; Heyes, M. P.

In: Biochemical Journal, Vol. 291, No. 1, 01.01.1993, p. 11-14.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-γ-stimulated monocytes (THP-1 cells)

AU - Saito, Kuniaki

AU - Chen, C. Y.

AU - Masana, M.

AU - Crowley, J. S.

AU - Markey, S. P.

AU - Heyes, M. P.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following-induction of indoleamine 2,3-dioxygenase and other kynurenine-pathway enzymes. In the present study a survey of various cell lines derived from either brain or systemic tissues showed that, while all cells examined responded to interferon-γ by increased conversion of L[13C6]tryptophan into L-kynurenine (human: B-lymphocytes neuroblastoma, glioblastoma, lung, liver, kidney; rat brain microglia, astrocytes and oligodendrocytes), only macrophage-derived cells (peripheral-blood mononuclear cells; THP-1, U-937) and certain liver cells (SKHep1) synthesized [13C6]quinolinic acid. Tumour necrosis factor-α enhanced the effects of interferon-γ in THP-1 cells. Norharmane, 6-chloro-DL-tryptophan and 4-chloro-3-hydroxyanthranilate attenuated quinolinic acid formation by THP-1 cells with IC50 values of 51μM, 58μM and 0.11μM respectively. Norharmane and 6-chloro-DL-tryptophar attenuated L-kynurenine formation with IC50 values of 43μM and 51μM respectively, whereas 4-chloro-3-hydroxyanthranilate had no effect on L-kynurenine accumulation. The reductions in L-kynurenine and quinolinic acid formation are consistent with the reports that norharmane is an inhibitor of indoleamine 2,3-dioxygenase, 6-chloro-DL-tryptophan is metabolized through the kynurenine pathway, and 4-chloro-3-hydroxyanthranilate is an inhibitor of 3-hydroxyanthranilate 3,4-dioxygenase. These results suggest that many tissues may contribute to the production of L-kynurenine following indoleamine 2,3-dioxygenase induction and immune activation. Quinolinic acid may be directly synthesized from L-tryptophan in both macrophages and certain types of liver cells, although uptake of quinolinic acid precursors from blood may contribute to quinolinic acid synthesis in cells that cannot convert L-kynurenine into quinolinic acid.

AB - Accumulation of quinolinic acid and L-kynurenine occurs in the brain and/or blood following immune activation, and may derive from L-tryptophan following-induction of indoleamine 2,3-dioxygenase and other kynurenine-pathway enzymes. In the present study a survey of various cell lines derived from either brain or systemic tissues showed that, while all cells examined responded to interferon-γ by increased conversion of L[13C6]tryptophan into L-kynurenine (human: B-lymphocytes neuroblastoma, glioblastoma, lung, liver, kidney; rat brain microglia, astrocytes and oligodendrocytes), only macrophage-derived cells (peripheral-blood mononuclear cells; THP-1, U-937) and certain liver cells (SKHep1) synthesized [13C6]quinolinic acid. Tumour necrosis factor-α enhanced the effects of interferon-γ in THP-1 cells. Norharmane, 6-chloro-DL-tryptophan and 4-chloro-3-hydroxyanthranilate attenuated quinolinic acid formation by THP-1 cells with IC50 values of 51μM, 58μM and 0.11μM respectively. Norharmane and 6-chloro-DL-tryptophar attenuated L-kynurenine formation with IC50 values of 43μM and 51μM respectively, whereas 4-chloro-3-hydroxyanthranilate had no effect on L-kynurenine accumulation. The reductions in L-kynurenine and quinolinic acid formation are consistent with the reports that norharmane is an inhibitor of indoleamine 2,3-dioxygenase, 6-chloro-DL-tryptophan is metabolized through the kynurenine pathway, and 4-chloro-3-hydroxyanthranilate is an inhibitor of 3-hydroxyanthranilate 3,4-dioxygenase. These results suggest that many tissues may contribute to the production of L-kynurenine following indoleamine 2,3-dioxygenase induction and immune activation. Quinolinic acid may be directly synthesized from L-tryptophan in both macrophages and certain types of liver cells, although uptake of quinolinic acid precursors from blood may contribute to quinolinic acid synthesis in cells that cannot convert L-kynurenine into quinolinic acid.

UR - http://www.scopus.com/inward/record.url?scp=0027408778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027408778&partnerID=8YFLogxK

U2 - 10.1042/bj2910011

DO - 10.1042/bj2910011

M3 - Article

C2 - 8471029

AN - SCOPUS:0027408778

VL - 291

SP - 11

EP - 14

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 1

ER -